Serina Therapeutics

Ukraine
Brusnytsia, Chernivtsi, Ukraine, 35806

Company profile

Serina Therapeutics company profile

Serina Therapeutics is a privately-held pharmaceutical company that is advancing novel therapeutics for cancer, inflammation, pain, and metabolic disorders using its proprietary polymer technology. They have created new pharmaceutical candidates using polyoxazoline (POZ), a safe, water-soluble polymer to which they can attach a variety of small molecules, proteins, peptides, and DNA. The attachment of these molecules to polymers of POZ typically confers a unique pharmacokinetic profile that is markedly different from the parent compound, and this profile may confer advantages in terms of safety and efficacy.

Business identity

Contact email
[email protected]
Phone number
256-327-0566
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2007-01-01, Year

Headquarters

Postal code
35806
Country code
UA
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
10
Total equity funding
$45.7M
Last funding
Post IPO Debt / $5M / 2025-10-06
Last equity funding
Post IPO Equity / $5M
Investors
3
Lead investors
3
Founders
1
Articles
153
Exited on
2024-03-27

Founders and investors

Founders

Michael Bentley

Lead investors

Greg BaileyInnovate AlabamaJuvVentures

Investors

Greg BaileyInnovate AlabamaJuvVentures